
Opinion|Videos|May 17, 2024
Research Landscape: Endocrine Therapies for ER+/HER2- Metastatic Breast Cancer
Author(s)Stephanie L. Graff, MD
Stephanie Graff, MD, concludes the discussion with thoughts on endocrine therapies in development for patients with ER+/HER2- metastatic breast cancer.
Advertisement
Episodes in this series

Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
5 AI and Digital Health Advances Transforming Breast Cancer Care and Research
2
CD19 CAR T-Cell Therapy Shows Promising Activity in Richter Transformation
3
Can a Coffee a Day Keep AFib Away?
4
2025 Hypertension Guideline Updates Presented at AHA Scientific Sessions
5













































